Kevin Walsh

5PUBLICATIONS
33CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 05, 2026
Characterization of T Cell Engaging Bispecific Antibodies and Combination Therapies with a High-Throughput Multiparametric Automated Assay and Data Analysis Platform.

|Aug 07, 2024
NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunity.

Aurelie Herault, Judy Mak, Josefa de la Cruz-Chuh

|Apr 03, 2020
Anti-VEGF Treatment Enhances CD8<sup>+</sup> T-cell Antitumor Activity by Amplifying Hypoxia.

Patricia E de Almeida, Judy Mak, Genevive Hernandez

|Mar 30, 2020
MAP4K4 negatively regulates CD8 T cell-mediated antitumor and antiviral immunity.

Emel Esen, Ismail Sergin, Rajiv Jesudason

|Sep 13, 2018
The Hippo pathway effector TAZ induces TEAD-dependent liver inflammation and tumors.

Thijs J Hagenbeek, Joshua D Webster, Noelyn M Kljavin

Pageof 1

Frequent Collaborators

1 joint publications

Thijs J Hagenbeek

1 joint publications

Noelyn M Kljavin

1 joint publications

Ho-June Lee

1 joint publications

Christiaan Klijn